Neurologia i Neurochirurgia Polska

Papers
(The TQCC of Neurologia i Neurochirurgia Polska is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns29
Early post-stroke rehabilitation for upper limb motor function using virtual reality and exoskeleton: equally efficient in older patients29
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience23
COVID-19-related headache and innate immune response — a narrative review21
Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment21
Does amantadine have a protective effect against COVID-19?18
Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome15
Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)15
The role of fibrinogen in acute ischaemic stroke15
COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish15
Nusinersen treatment of Spinal Muscular Atrophy Type 1 — results of expanded access programme in Poland14
Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome14
Neurological and neurourological complications of electrical injuries12
Genetics of Parkinson’s disease in the Polish population11
Prevalence of cognitive impairment in acute ischaemic stroke and use of Alberta Stroke Programme Early CT Score (ASPECTS) for early prediction of post-stroke cognitive impairment11
Advancing gene therapies, methods, and technologies for Parkinson’s Disease and other neurological disorders11
Cannabis and cannabinoids: pharmacology and therapeutic potential10
Cervical dystonia — improving the effectiveness of botulinum toxin therapy10
What can Parkinson’s disease teach us about COVID-19?10
Gastrostomy and mechanical ventilation in amyotrophic lateral sclerosis: how best to support the decision-making process?10
First Polish case of CSF1R-related leukoencephalopathy10
Changes in cervical range of motion following anterior cervical discectomy with fusion — preliminary results9
Botulinum toxin type-A preparations are not the same medications — basic science (Part 1)9
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue9
Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality9
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with an A792D mutation in the CSF1R gene in a Polish patient9
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)9
Smoking as a risk factor of onset and relapse of Multiple Sclerosis — a review9
Nucleus accumbens as a stereotactic target for the treatment of addictions in humans: a literature review8
Use of cannabidiol in the treatment of epilepsy8
Vestibular migraine — an underdiagnosed cause of vertigo. Diagnosis and treatment8
Vigabatrin — new data on indications and safety in paediatric epilepsy8
Pitfalls in diagnosing Wilson’s Disease by genetic testing alone: the case of a 47-year-old woman with two pathogenic variants of the ATP7B gene8
Post-COVID 19 Neurological Syndrome: a fresh challenge in neurological management8
Pneumocephalus as a rare complication: a systematic review plus clinical vignette7
Differences in acute ischaemic stroke care in Poland: analysis of claims database of National Health Fund in 20177
Cannabis in Parkinson’s Disease — the patient’s perspective versus clinical trials: a systematic literature review7
Neuro-COVID-19: an insidious virus in action7
Time matters greatly in acute stroke care7
Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus7
D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson’s Disease7
Impact of COVID-19 on incidence and treatment of intracranial aneurysms in Poland: a national study6
Variability in melatonin concentration in blood serum of patients with episodic migraine: a pilot study6
Importance of non-motor symptoms in PD and atypical parkinsonism6
Secondary progressive multiple sclerosis — from neuropathology to definition and effective treatment6
Association between intention to call EMS in stroke patients and level of hospital classification and emergency medical service usage among stroke patients in China6
Spinocerebellar ataxia type 6 family with phenotypic overlap with Multiple System Atrophy6
Effects of sex and APOE on Parkinson’s Disease-related cognitive decline6
Trends in glioblastoma treatment research: an analysis of clinical trials and literature6
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors6
COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study6
Alzheimer’s disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities6
Preferred muscles in cervical dystonia6
Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances5
Botulinum neurotoxin in cervical dystonia revisited — recent advances and unanswered questions5
Sexual dysfunction in Huntington’s Disease — a systematic review5
Bed regime as a lifesaving factor in spontaneous intracranial hypotension5
Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy — an evidence-based review5
Predictors of outcome events and 6-year mortality after carotid endarterectomy and carotid stenting in patients with carotid artery stenosis5
Transvenous embolisation via an occluded inferior petrosal sinus for cavernous sinus dural arteriovenous fistulas5
Neurological manifestations of SARS-CoV-2 — a systematic review5
Fluoxetine for stroke recovery improvement – the doubleblind, randomised placebo-controlled FOCUS-Poland trial4
Does location matter? Characterisation of the anatomic locations, molecular profiles, and clinical features of gliomas4
Predictors of remission in patients with epilepsy4
Cerebral microbleeds in neurological practice: concepts, diagnostics and clinical aspects4
Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients4
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases4
Impact of SARS-CoV-2 on the nervous system4
Role of DTI-MRI parameters in diagnosis of ALS: useful biomarkers for daily practice? Tertiary centre experience and literature review4
Spontaneous spinal epidural haematoma: management and main risk factors in era of anticoagulant / antiplatelet treatment4
Migraine treatment recommendations developed by an Expert Group of the Polish Headache Society, the Headache Section of the Polish Neurological Society, and the Polish Pain Society4
Structural brain assessment of temporal lobe epilepsy based on voxel-based and surface-based morphological features4
Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report4
YouTube as a source of patient information on brain aneurysms: a content-quality and audience engagement analysis4
Screening and diagnosis for mood and anxiety disorders in epilepsy: Polish population reference values4
Multiple sclerosis immunomodulatory therapies tested for effectiveness in COVID-194
Stereotypies in adults: a systematic review4
Role of gadolinium-based contrast agents in neurological disorders4
Late onset multiple sclerosis — multiparametric MRI characteristics4
Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis4
Associations of optical coherence tomography with disability and brain MRI volumetry in patients with multiple sclerosis4
Double vision in Parkinson’s Disease: a systematic review4
Cardiovascular dysautonomia and cognition in Parkinson’s Disease — a possible relationship3
Predictors of cognitive impairment in pseudotumor cerebri3
Diagnostic value of diffusion tensor imaging in patients with clinical signs of cervical spondylotic myelopathy3
Mechanical thrombectomy for acute ischaemic stroke during therapeutic anticoagulation: long-term outcomes3
Facial onset sensory and motor neuronopathy syndrome — a rare variant of motor neurone disease3
The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) — recommendations of an expert working group3
The relation between plasma miR-126 levels and cerebral collateral circulation in patients with intracranial arterial stenosis3
Factors that may delay disappearance of trigeminal neuralgia after percutaneous balloon compression3
Ruptured temporal horn aneurysm associated with Moyamoya collateral vessel coexisting with contralateral arteriovenous malformation — technical note with clinical vignette3
Safety and tolerability of therapeutic plasma exchange in autoimmune neurological diseases — a retrospective single-centre analysis3
Lacosamide and myoclonic seizures: what is the risk of aggravation?3
Movement disorders associated with chromosomal aberrations diagnosed in adult patients3
Cross-circulation thrombectomy through posterior communicating artery for acute middle cerebral artery occlusion using Solitaire FR stent with intermediate catheter assisting technique3
Significant fall in stroke admissions in the Malopolska Voivodeship of Poland during the COVID-19 pandemic3
Fibrinogen concentrations in ischaemic stroke patients with metabolic disorders3
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic — when immunosuppression meets infection?3
Botulinum toxin type-A preparations are not the same medications — clinical studies (Part 2)3
Could hyperlipidemia be a risk factor for corticobasal syndrome? — a pilot study3
0.024310111999512